Sophie Elizabeth Claudel MD
Clinical Instructor, Nephrology
Resident Physician, Nephrology
72 East Concord Street | (617) 638-6500seclaude@bu.edu
Sections
Nephrology
Biography
Dr. Sophie Claudel is a Nephrology Fellow and early-career investigator at Boston Medical Center and the Boston University Chobanian & Avedisian School of Medicine. She earned her MD from the Wake Forest University School of Medicine and completed a clinical research fellowship at the National Institutes of Health. She completed her Internal Medicine residency and chief residency at Boston Medical Center through the NIH R38-funded Promoting Research in Medical Residency (PRIMER) pathway.
Dr. Claudel’s research examines the bidirectional relationship between chronic kidney disease and cardiovascular disease. By integrating epidemiology, clinical phenotyping, and physiologic studies, she aims to uncover shared mechanisms of disease and inform strategies for prevention. She is also a member of the CURE Consortium, a multinational research group investigating chronic kidney disease of unknown etiology (CKDu) in Central America and India focusing on identifying causal exposures and novel kidney biomarkers.
Publications
Wittig M, Verma A, Bellavia A, Rosan S, Claudel SE, Surapaneni A, Palsson R, Srivastava A, Stillman IE, Henderson JM, Beck LH, Hodgin JB, Grams ME, Rhee EP, Huber TB, Waikar SS, Schmidt IM. The Associations of Foot Process Effacement with Kidney Histopathologic Lesions and Disease Progression. Kidney360. 2025 Jul 29. PMID: 40728890.
Published on 5/2/2025Claudel SE, Waikar SS, Verma A. Albuminuria References Ranges in Healthy US Adults. J Appl Lab Med. 2025 May 02; 10(3):767-771. PMID: 39981782.
Published on 4/14/2025Solomon M, Claudel S, Verma A. Cardiovascular-Kidney-Metabolic Health: Definition, Staging, Risk Assessment, and Therapeutic Considerations. Cardiol Clin. 2025 Aug; 43(3):337-357. PMID: 40582729.
Published on 4/1/2025Claudel SE, Schmidt IM, Waikar SS, Verma A. Albuminuria: A Marker of Adverse Kidney Outcomes in Heart Failure. J Am Coll Cardiol. 2025 Apr 01; 85(12):1372-1375. PMID: 40139894.
Published on 3/17/2025Schmidt IM, Verma A, Claudel SE, Palsson R, Srivastava A, Stillman IE, Beck LH, Waikar SS. Genetic Testing in Biopsy-Confirmed Kidney Disease. Kidney Med. 2025 May; 7(5):100994. PMID: 40321977.
Published on 3/10/2025Claudel SE, Verma A. Albuminuria in Cardiovascular, Kidney, and Metabolic Disorders: A State-of-the-Art Review. Circulation. 2025 Mar 11; 151(10):716-732. PMID: 40063723.
Published on 2/11/2025Claudel SE, Schmidt IM, Waikar SS, Verma A. Cumulative Incidence of Mortality Associated with Cardiovascular-Kidney-Metabolic (CKM) Syndrome. J Am Soc Nephrol. 2025 Feb 11; 36(7):1343-1351. PMID: 39932805.
Published on 2/6/2025Kothari OA, Stone J, Manivannan A, Segarra-Concepcion A, Ferri GM, Ganti R, Gurnani SD, Gurijala N, Toro C, Bosch NA, Claudel SE. Statin Use and Cardiovascular Risk in Young Adults in the United States. Am J Prev Med. 2025 May; 68(5):1028-1031. PMID: 39922395.
Published on 12/11/2024Claudel SE, Verma A. Social Determinants of Health and Cumulative Incidence of Mortality Among US Adults Without Major Chronic Diseases. J Gen Intern Med. 2025 May; 40(7):1527-1537. PMID: 39663346.
Published on 12/4/2024Claudel SE, Waikar SS, Schmidt IM, Vasan RS, Verma A. The relationship between low levels of albuminuria and mortality among adults without major cardiovascular risk factors. Eur J Prev Cardiol. 2024 Dec 04; 31(17):2046-2055. PMID: 38825979.